Denosumab-Associated Severe Hypocalcemia in Dialysis-Dependent Patients-Reply

JAMA. 2024 Jun 4;331(21):1865-1866. doi: 10.1001/jama.2024.6842.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Bone Density Conservation Agents* / adverse effects
  • Bone Density Conservation Agents* / therapeutic use
  • Denosumab* / adverse effects
  • Denosumab* / therapeutic use
  • Humans
  • Hypocalcemia* / chemically induced
  • Kidney Failure, Chronic* / complications
  • Kidney Failure, Chronic* / therapy
  • Renal Dialysis*

Substances

  • Bone Density Conservation Agents
  • Denosumab